Head-to-head · WeighScore
Pepti vs T2D.com
The verdict
Pepti takes it — 78.8/100 to 53/100.
Pepti grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pepti prices both molecules all-in with no membership fee, names its medical director, and still carries an FDA-cleared badge on a homepage whose product pages say the opposite.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Pepti | T2D.com |
|---|---|---|
| WeighScore | 78.8/100 | 53/100 |
| Grade | C+ | C |
| Site position | #44 | #516 |
| Semaglutide | $109 per 28 days (all-in; billing can fall twice in one calendar month) | $999/mo (starting dose, compounded) |
| Tirzepatide | $179 per 28 days (all-in; billing can fall twice in one calendar month) | $999/mo (starting dose, compounded) |
| Coverage | All 50 states plus Washington, D.C. | 1 state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Site position #44 · C+
Strengths
- The figure is stated as the full price with no membership fee, free shipping included, on the product page itself
- Names a medical director by name and board certification, and a second named provider
- Baseline labs are described as included when a clinician requires them, with deeper panels priced openly at $149 and a $129 monthly bloodwork plan
- Coverage is all 50 states and the District of Columbia, stated without a hedge
- Roughly forty prescription peptide products are priced alongside the GLP-1 lines
Where it loses points
- The site prints $79 on its own semaglutide cost page and $109 on the same page, and $149 against $179 for tirzepatide; the figures that transact are $109 and $179
- The product pages label the figure an all-in monthly price while the billing terms set the cycle at 28 days and warn it can bill twice in one calendar month
- An “FDA cleared” badge sits in the homepage trust cluster while the product pages state that compounded medication is neither FDA-approved nor FDA-cleared
- “Our pharmacy partners” names exactly one, Olympia, with no legal entity or address, while the same page says the filling pharmacy varies by patient
- Payment is taken before a physician reviews the intake, and the refund is the remedy
- Labs are conditional rather than included, despite plan copy that reads as though they are standard
Site position #516 · C
Strengths
- Built specifically for type 2 diabetic and pre-diabetic patients
- Integrated service — prescriber, pharmacy, and delivery handled in one flow
- Offers both compounded semaglutide and compounded tirzepatide
- Temperature-controlled home delivery via UPS or FedEx
- Ongoing prescriber monitoring and support included
Where it loses points
- No pricing published on the public website — must register to see costs
- No states list published on the site
- Newer brand with limited independent reviews
- Compounded only — no brand-name Ozempic, Wegovy, or Mounjaro
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.